Wrinkles

... Breaking News: Q-Med: Year-End Report 2005 BODY { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: #ececec; PADDING-BOTTOM: 0px; MARGIN: 0px; FONT: 85% Arial, Helvetica, sans-serif; PADDING-TOP: 0px } Log in Register Now UPDATED 2/10/2006 2:07:00 AM EST Contact Us Mary Ann Liebert, Inc.

About GEN Home In The News Breaking News Sticky Ends Online Current Issue New Products On The Web Past Issues e-Newsletters Calendar of Events Classifieds View Listings Submit a Listing Web Resources Subscribe to GEN Reprints Advertise in GEN Media Kit Mailing List Rental Partnership Opportunities Editorial Editorial Calendar Meet the GEN Editors Editorial Guidelines Gen database of Biotech Firms Home » In The News » Breaking News Breaking News Email article to a colleague Printer friendly version Q-Med: Year-End Report 2005 2/10/2006 2:07:00 AM EST Q-Med: - Turnover during 2005 rose by 19 percent to SEK 976.0 (823.2) million.

- Operating income amounted to SEK 111.7 (339.4) million.

Adjusted for revenues and expenses of a one-time nature, operating income amounted to SEK122.6 (25.5) million.

- Net income after tax amounted to SEK 77.1(257.8) million.

- Earnings per share before dilution amounted to SEK 3.11 (10.39).

- Continued very positive sales development within the Hospital Healthcare product area, +54 percent.

- Registration study on RESTYLANE in China was c...

Read more...